Imagine trying to find a very specific tool for a complex repair, but the tools are scattered across 10 different countries in locked warehouses. This project creates a single digital storefront where researchers can find and book over 500 specialized cancer-fighting tools and services in one place. It handles the paperwork and tracking, making it as easy as shopping online to get high-tech lab work done across Europe.
Cancer researchers and biotech companies struggle to find and access specialized laboratory services across Europe due to fragmented systems and complex administrative hurdles.
A Common Access Management System (CAMS) and a searchable digital catalogue of 531 oncology services.
If you are a drug discovery firm dealing with the difficulty of finding specialized oncology labs for testing — this project developed a catalogue of 531 cutting-edge services that streamlines the selection and submission of research proposals.
If you are a precision medicine startup dealing with fragmented access to biobanks — this project developed a Common Access Management System (CAMS) that tracks the process from approval to delivery for oncology services.
If you are a diagnostic developer dealing with inconsistent data standards across European labs — this project developed a system ensuring data is fully compliant with FAIR principles to make results usable across different platforms.
Based on available project data, specific pricing is not mentioned; however, the project establishes a Common Access Management System (CAMS) to handle the submission and review of research proposals.
Yes, the project aims to scale up to a pan-European collaboration of research infrastructures to accelerate solutions for the cancer patient community.
Based on available project data, the project focuses on the governance of access and data compliance with FAIR principles rather than specific IP licensing terms.
It integrates via a unified catalogue and a Common Access Management System (CAMS) that tracks the entire process from approval through delivery to conclusion.
The project runs from 2022-09-01 to 2026-08-31, with the catalogue already containing 531 services as of the second reporting period.
The consortium is heavily weighted toward research and academic institutions, with 12 research organizations and 4 universities. While industry representation is low at 11% (2 partners), the network is powerful because it connects 17 world-class research infrastructures (including BBMRI and ELIXIR), providing a massive operational footprint across 10 European countries.
Contact BBMRI-ERIC in Austria
Contact us to identify the specific oncology service provider from the 167 available that fits your R&D needs.
